Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73916/1/j.1749-6632.1988.tb31828.x.pd
The pathophysiology of Parkinson's disease is marked by the loss of dopaminergic neurons, which lead...
Parkinson’s disease is a movement disorder, caused predominantly by the degeneration of the dopamine...
Parkinson's disease is a progressive neurodegenerative disorder, characterized by a loss of dopamine...
Although the administration of dopamine precursor levodopa remains as the mainstay for the treatment...
Introduction: The clinical diagnosis of Parkinson’s disease (PD) is based on the identification of b...
A thesis submitted to the Faculty of Medicine, University of the Witwatersrand, Johannesburg, for ...
The cynomolgus monkeys received a unilateral intracarotid injection of the neurotoxin N-methyl-4-phe...
International audienceBACKGROUND:Levodopa effectively relieves motor symptoms in Parkinson's disease...
Parkinson’s disease (PD) is the 2nd most common neurodegenerative disorder due to gradual loss of do...
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate models of Parkinson’s disease (PD) r...
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evid...
Animal models for neuropsychiatric disorders are implemented for the purpose of investigating a sing...
The aim of this study was twofold: (1) to study the predictive validity of the drug-naive, bilateral...
Major limitations to the pharmacotherapy of Parkinson's disease (PD) are the motor complications res...
Item does not contain fulltextThe goal of this study was to evaluate the validity of the pretreated,...
The pathophysiology of Parkinson's disease is marked by the loss of dopaminergic neurons, which lead...
Parkinson’s disease is a movement disorder, caused predominantly by the degeneration of the dopamine...
Parkinson's disease is a progressive neurodegenerative disorder, characterized by a loss of dopamine...
Although the administration of dopamine precursor levodopa remains as the mainstay for the treatment...
Introduction: The clinical diagnosis of Parkinson’s disease (PD) is based on the identification of b...
A thesis submitted to the Faculty of Medicine, University of the Witwatersrand, Johannesburg, for ...
The cynomolgus monkeys received a unilateral intracarotid injection of the neurotoxin N-methyl-4-phe...
International audienceBACKGROUND:Levodopa effectively relieves motor symptoms in Parkinson's disease...
Parkinson’s disease (PD) is the 2nd most common neurodegenerative disorder due to gradual loss of do...
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate models of Parkinson’s disease (PD) r...
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evid...
Animal models for neuropsychiatric disorders are implemented for the purpose of investigating a sing...
The aim of this study was twofold: (1) to study the predictive validity of the drug-naive, bilateral...
Major limitations to the pharmacotherapy of Parkinson's disease (PD) are the motor complications res...
Item does not contain fulltextThe goal of this study was to evaluate the validity of the pretreated,...
The pathophysiology of Parkinson's disease is marked by the loss of dopaminergic neurons, which lead...
Parkinson’s disease is a movement disorder, caused predominantly by the degeneration of the dopamine...
Parkinson's disease is a progressive neurodegenerative disorder, characterized by a loss of dopamine...
DOI
Add to ORKG